The Cerebellar Cognitive‐Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal‐Recessive Spastic Ataxia of Charlevoix‐Saguenay: A Large International Cross‐Sectional Study
Movement Disorders · 2026
DOI: 10.1002/mds.70201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2026. Verfasst von Julie Fortin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Groupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Sag…. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, Cerebellar Cognitive Affective Syndrome, Muscle Spasticity. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Joint Programme on Rare Diseases, EJP RD consortium TREAT-ARCA, European Union, project European Rare Disease Research Alliance (ERDERA).
Abstract (Originalsprache)
Background
Neuropsychological deficits have been observed in patients with cerebellar damage, but never thoroughly investigated in autosomal recessive spastic ataxia of Charlevoix‐Saguenay (ARSACS).
Objectives
The goal is the characterization of presence, severity, and profile of neuropsychological deficits in ARSACS using the cerebellar cognitive‐affective syndrome (CCAS) scale.
Methods
Prospective study including a discovery cohort from Saguenay/Canada (n = 31, median [inter‐quartile range] age: 57 [54–62] years), and a validation cohort from Tübingen, Germany (n = 17, 35 [21–43] years) with matched controls (n = 19).
Results
All ARSACS patients failed in multiple CCAS‐related subtests and exceeded cutoffs for “definite CCAS.” Even the younger validation cohort failed more subtests than controls (5 [3–7] vs. 1 [1–2], P < 0.001) and had lower CCAS total scores (81 [67–86] vs. 101 [91–106], P < 0.001). Total scores worsened in the older discovery cohort (40 [25–52], P < 0.001) and correlated with age/disease duration (ρ = −0.575, P < 0.001) and ataxia severity (Scale for the Assessment and Rating of Ataxia: ρ = −0.527, P = 0.003).
Conclusions
Neuropsychological deficits consistent with CCAS are consistent in ARSACS, present early, and progress in the disease course. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Groupe de Recherche Interdisciplinaire sur les Maladies Neuromusculaires (GRIMN), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-St-Jean, Hôpital de Jonquière, Saguenay, Québec, Canada.
- Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Québec, Canada.
- Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
- Department of Neurology and Center for Translational Neuro- and Behavioral StudiesSciences (C-TNBS), Essen University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
- Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Julie Fortin, Matthis Synofzik, Élyse-Anne Pedneault-Tremblay, Dominik Hermle, Andreas Thieme, Dagmar Timmann, Roberta La Piana, Bernard Brais, Isabelle Côté, Cynthia Gagnon, Andreas Traschütz
Förderung
- European Joint Programme on Rare Diseases
- EJP RD consortium TREAT-ARCA
- European Union, project European Rare Disease Research Alliance (ERDERA)
- HORIZON-HLTH-2023-DISEASE-07
- Clinician Scientist program "PRECISE.net"
- Consortium international, including the Canadian Institutes of Health Research, Ataxia Charlevoix-Saguenay Foundation and Muscular Dystrophy Canada
- European Commission
Zitieren
APA
Fortin, J., Synofzik, M., Pedneault-Tremblay, É. A., Hermle, D., Thieme, A., Timmann, D., La Piana, R., Brais, B., Dolbec, J., Côté, I., Gagnon, C., & Traschütz, A. (2026). The Cerebellar Cognitive‐Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal‐Recessive Spastic Ataxia of Charlevoix‐Saguenay: A Large International Cross‐Sectional Study. Movement Disorders. https://doi.org/10.1002/mds.70201
Vancouver
Fortin J, Synofzik M, Pedneault-Tremblay ÉA, Hermle D, Thieme A, Timmann D, et al. The Cerebellar Cognitive‐Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal‐Recessive Spastic Ataxia of Charlevoix‐Saguenay: A Large International Cross‐Sectional Study. Movement Disorders. 2026. doi:10.1002/mds.70201
BibTeX
@article{Fortin2026,
author = {Fortin, Julie and Synofzik, Matthis and Pedneault-Tremblay, Élyse-Anne and Hermle, Dominik and Thieme, Andreas and Timmann, Dagmar and La Piana, Roberta and Brais, Bernard and Dolbec, Justine and Côté, Isabelle and Gagnon, Cynthia and Traschütz, Andreas},
title = {The Cerebellar Cognitive‐Affective Syndrome Scale Reveals Consistent, Early, and Progressive Neuropsychological Deficits in Autosomal‐Recessive Spastic Ataxia of Charlevoix‐Saguenay: A Large International Cross‐Sectional Study},
journal = {Movement Disorders},
year = {2026},
doi = {10.1002/mds.70201}
}
EUVIMED